Impact of respiratory gating and ECG gating on 18F-FDG PET/CT for cardiac sarcoidosis

J Nucl Cardiol. 2023 Oct;30(5):1879-1885. doi: 10.1007/s12350-023-03236-0. Epub 2023 Mar 14.

Abstract

Background: The aim of this study was to estimate the impact of respiratory and electrocardiogram (ECG)-gated FDG positron emission tomography (PET)/computed tomography (CT) on the diagnosis of cardiac sarcoidosis (CS).

Methods and results: Imaging from thirty-one patients was acquired on a PET/CT scanner equipped with a respiratory- and ECG-gating system. Non-gated PET images and three kinds of gated PET/CT images were created from identical list-mode clinical PET data: respiratory-gated PET during expiration (EX), ECG-gated PET at end diastole (ED), and ECG-gated PET at end systole (ES). The maximum standardized uptake value (SUVmax) and cardiac metabolic volume (CMV) were measured, and the locations of FDG accumulation were analyzed using a polar map. The mean SUVmax of the subjects was significantly higher after application of either respiratory-gated or ECG-gated reconstruction. Conversely, the mean CMV was significantly lower following the application of respiratory-gated or ECG-gated reconstruction. The segment showing maximum accumulation was shifted to the adjacent segment in 25.8%, 38.7%, and 41.9% of cases in EX, ED, and ES images, respectively.

Conclusion: In FDG PET/CT scanning for the diagnosis of CS, gated scanning is likely to increase quantitative accuracy, but the effect depends on the location and synchronization method.

Keywords: ECG-gated PET; FDG; cardiac sarcoidosis; respiratory-gated PET.

MeSH terms

  • Cytomegalovirus Infections*
  • Electrocardiography
  • Fluorodeoxyglucose F18
  • Humans
  • Positron Emission Tomography Computed Tomography
  • Positron-Emission Tomography / methods
  • Sarcoidosis* / diagnostic imaging

Substances

  • Fluorodeoxyglucose F18